Clinical evaluation of free PSA total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer

被引：14
|
作者：
Filella, X [1 ]
Alcover, J [1 ]
Molina, R [1 ]
Rodriguez, A [1 ]
Carretero, P [1 ]
Ballesta, AM [1 ]
机构：
[1] HOSP CLIN BARCELONA,DEPT UROL,BARCELONA 08036,SPAIN
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷 / 08期
关键词：
PSA; free PSA; prostate cancer;
D O I：
10.1016/S0959-8049(97)00081-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The objective of this study was to evaluate the utility of the free/total prostate-specific antigen (PSA) ratio (per cent free PSA) in the diagnosis of prostate cancer. Serum total PSA and free PSA concentrations were measured in 156 patients with benign prostate hyperplasia (BPH) and 74 patients with prostate cancer using Hybritech Tandem immunoradiometric assays. Patients with prostate cancer had a significantly lower free/total PSA ratio than patients with BPH, although the distributions across study groups overlapped. In patients with a total PSA level between 4 mu g/l and 25 mu g/l, free/total PSA demonstrated better diagnostic utility than total PSA alone. (C) 1997 Published by Elsevier Science Ltd.
引用
收藏
页码：1226 / 1229
页数：4
相关论文
共 50 条
  • [21] PROSTATE-SPECIFIC ANTIGEN (PSA) IN PROSTATE DISEASE
    PEYRET, C
    LEROY, M
    TEILLAC, P
    RABAUD, B
    NAJEAN, Y
    LEDUC, A
    JOURNAL DE BIOPHYSIQUE ET DE BIOMECANIQUE, 1987, 11 (03): : 125 - 125
  • [22] An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: Results on 4298 cases
    Carlson, GB
    Calvanese, CB
    Partin, AW
    UROLOGY, 1998, 52 (03) : 455 - 461
  • [23] Prostate specific antigen (PSA) value adjusted for transition zone volume and free PSA (γ-seminoprotein)/PSA ratio in the diagnosis of prostate cancer in patients with intermediate PSA levels
    Kurita, Y
    Terada, H
    Masuda, H
    Suzuki, K
    Fujita, K
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (02): : 224 - 230
  • [24] The influence of serial prostate-specific antigen (PSA) screening on the PSA velocity at diagnosis
    Martin, Neil E.
    Chen, Ming-Hui
    Catalona, William J.
    Loeb, Stacy
    Roehl, Kimberly A.
    D'Amico, Anthony V.
    CANCER, 2008, 113 (04) : 717 - 722
  • [25] Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment
    Kim, Dae Il
    Song, Jae Mann
    Chung, Hyun Chul
    KOREAN JOURNAL OF UROLOGY, 2012, 53 (03) : 149 - 153
  • [26] Prostate-specific antigen (PSA) and PSA density: Racial differences in men without prostate cancer
    Henderson, RJ
    Eastham, JA
    Culkin, DJ
    Kattan, MW
    Whatley, T
    Mata, J
    Venable, D
    Sartor, O
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (02) : 134 - 138
  • [27] Prostate-specific antigen (PSA): An overview
    Manji, M
    ANNALS OF SAUDI MEDICINE, 2002, 22 (1-2) : 1 - 3
  • [28] PROSTATE-SPECIFIC ANTIGEN (PSA) - INTRODUCTION
    HULAND, H
    UROLOGE-AUSGABE A, 1995, 34 (04): : 273 - 274
  • [29] Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA
    Severi, Gianluca
    Hayes, Vanessa M.
    Neufing, Petra
    Padilla, Emma J. D.
    Tilley, Wayne D.
    Eggleton, Sarah A.
    Morris, Howard A.
    English, Dallas R.
    Southey, Melissa C.
    Hopper, John L.
    Sutherland, Robert L.
    Boyle, Peter
    Giles, Graham G.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (06) : 1142 - 1147
  • [30] BIOCHEMISTRY OF PROSTATE-SPECIFIC ANTIGEN, PSA
    MALM, J
    LILJA, H
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 : 15 - 22
12345